WallStreetZenWallStreetZen

NASDAQ: CYTH
Cyclo Therapeutics Inc Stock

$1.39-0.01 (-0.71%)
Updated Mar 28, 2024
CYTH Price
$1.39
Fair Value Price
N/A
Market Cap
$39.91M
52 Week Low
$0.67
52 Week High
$2.57
P/E
-1.13x
P/B
8.39x
P/S
24.12x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.08M
Earnings
-$20.06M
Gross Margin
92.2%
Operating Margin
-1,863.36%
Profit Margin
-1,863.4%
Debt to Equity
1.79
Operating Cash Flow
-$16M
Beta
0.87
Next Earnings
May 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CYTH Overview

Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company developing cyclodextrin-based products for the treatment of various diseases. It also sells cyclodextrins and related products to pharmaceutical and nutritional companies for use in diagnostics and specialty drugs. Known as CTD Holdings, Inc. until 2019, Cyclo Therapeutics was incorporated in 1990 and is based in Gainesville, FL.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CYTH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CYTH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CYTH is poor value based on its book value relative to its share price (8.39x), compared to the US Drug Manufacturers - Specialty & Generic industry average (2.19x)
P/B vs Industry Valuation
CYTH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CYTH due diligence checks available for Premium users.

Be the first to know about important CYTH news, forecast changes, insider trades & much more!

CYTH News

Valuation

CYTH fair value

Fair Value of CYTH stock based on Discounted Cash Flow (DCF)
Price
$1.39
Fair Value
$1.96
Undervalued by
29.22%
CYTH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CYTH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.13x
Industry
54.21x
Market
44.51x

CYTH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.39x
Industry
2.19x
CYTH is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CYTH's financial health

Profit margin

Revenue
$311.4k
Net Income
-$5.6M
Profit Margin
-1,812%
CYTH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CYTH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$13.2M
Liabilities
$8.5M
Debt to equity
1.79
CYTH's short-term assets ($12.32M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CYTH's short-term assets ($12.32M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CYTH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CYTH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.3M
Investing
-$2.4k
Financing
$11.7M
CYTH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CYTH vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
CYTH$39.91M-0.71%-1.13x8.39x
DRRX$37.55M-9.70%-1.15x2.54x
BGXX$44.87M-5.06%-4.07x2.87x
RMTI$48.70M+1.22%-4.49x2.29x
HUGE$28.18M+0.85%-1.67x2.62x

Cyclo Therapeutics Stock FAQ

What is Cyclo Therapeutics's quote symbol?

(NASDAQ: CYTH) Cyclo Therapeutics trades on the NASDAQ under the ticker symbol CYTH. Cyclo Therapeutics stock quotes can also be displayed as NASDAQ: CYTH.

If you're new to stock investing, here's how to buy Cyclo Therapeutics stock.

What is the 52 week high and low for Cyclo Therapeutics (NASDAQ: CYTH)?

(NASDAQ: CYTH) Cyclo Therapeutics's 52-week high was $2.57, and its 52-week low was $0.67. It is currently -45.91% from its 52-week high and 107.46% from its 52-week low.

How much is Cyclo Therapeutics stock worth today?

(NASDAQ: CYTH) Cyclo Therapeutics currently has 28,715,740 outstanding shares. With Cyclo Therapeutics stock trading at $1.39 per share, the total value of Cyclo Therapeutics stock (market capitalization) is $39.91M.

Cyclo Therapeutics stock was originally listed at a price of $118.80 in May 3, 2000. If you had invested in Cyclo Therapeutics stock at $118.80, your return over the last 23 years would have been -98.83%, for an annualized return of -17.58% (not including any dividends or dividend reinvestments).

How much is Cyclo Therapeutics's stock price per share?

(NASDAQ: CYTH) Cyclo Therapeutics stock price per share is $1.39 today (as of Mar 28, 2024).

What is Cyclo Therapeutics's Market Cap?

(NASDAQ: CYTH) Cyclo Therapeutics's market cap is $39.91M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cyclo Therapeutics's market cap is calculated by multiplying CYTH's current stock price of $1.39 by CYTH's total outstanding shares of 28,715,740.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.